CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
Nov 22, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in lieu thereof); the shares were priced at-the-market under NASDAQ rules. The announcement also noted that InMed issued unregistered preferred investment options to the investors in the offering to purchase up to 3,272,733 common shares. The offering resulted in approximately $6 million in gross proceeds for the company, which plans to use the funds to continue pipeline development of its pharmaceutical drug candidates as well as advance manufacturing know-how of cannabinoids and cannabinoid analogs; the company may also use portions of the proceeds to support intellectual property development and other commercial activities and for general working capital purposes. According to the announcement, H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
To view the full press release, visit https://cnw.fm/YjKA9
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, please visit www.InMedPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.
More News
'We screwed up': Doordash admits underpaying New York workers
The food delivery giant will pay a $131.5m settlement following a city probe into wage violations.
Global Oil Price Drops Below $100 a Barrel
Investors anticipated that a damaged Saudi Arabian pipeline may be close to reopening, allowing more oil from the region to reach world markets.
Trump Is Back on TV, Briefly, as Many Networks Carry His U.N. Speech Live
A suspension of pool coverage remains in effect. But the in-house United Nations broadcaster provided a feed of the president’s remarks.
Sir Jim Ratcliffe suspends production at key UK plants blaming high gas prices
Ineos said natural gas in the UK is twelve times more expensive than in the US.
How Unions Are Confronting A.I. Threats in the Workplace
The machinists union shows how workers are negotiating for a say in the ways artificial intelligence is used in their workplaces.
What Is the White House Press Pool, and Why Did It Suspend TV Coverage of Trump?
By barring CNN, the White House has thrown a staple of TV news coverage into disarray.
CNN’s Future Will Include an Editorial Oversight Board
The looming ownership of the network by David Ellison has caused anxiety in its newsroom for months.
What’s Next for Paramount
Hollywood watchers believe the studio prevailed over states seeking to block its deal for Warner Bros. Discovery. It’s now free to reshape the media industry.
China’s Continued Control of Rare Earths Looms Over Trump-Xi Meeting
Manufacturers are struggling with constrained supplies as U.S. and Chinese officials negotiate over export restrictions with consequences for global industry.
Paramount settles lawsuit with US states, clearing way for $110bn merger with Warner Bros
The deal includes an agreement to produce 30 films a year, or Paramount will be forced to sell off parts of its company.
Are vet bills about to get cheaper?
Written prescription fees from vets will be capped at £21 as part of a raft of changes that practices will be legally required to bring in over the coming months.
Spain battles climate change on several fronts
A summer of wildfires and heatwaves underlines the threats to the country's economy.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.